SABSW Financials
SAB Biotherapeutics Inc - Financial statements & key metrics
Stock Price
$0.03
Market Cap
-
P/E Ratio
0.0
EPS
$-3.68
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$1.32M
Gross Profit
-
Operating Income
-
Net Income
$-34.11M
EPS (Diluted)
$-3.68
Cash Flow Highlights
Operating Cash Flow
$-34.29M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Net Margin
-2579.0%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is SABSW revenue?
SABSW's most recent quarterly revenue was $1.32M. Annual revenue can be calculated by summing the four most recent quarters.
Is SABSW profitable?
SABSW reported a loss of $34.11M in the most recent quarter. The net profit margin is -2579.0%.
What is SABSW market cap?
Market cap data for SABSW is available above.
Does SABSW have debt?
View SABSW's balance sheet for debt information.
What is SABSW cash flow?
Cash flow data is available in the full financial statements.